SRA's number for the day: 3
This article was originally published in SRA
Executive Summary
Three drug companies have been “named and shamed” in the US by the Food and Drug Administration for failing to comply with the Pediatric Research Equity Act, legislation that requires companies to study their products in children in certain circumstances.